Sarana Meditama Metropolitan Tbk PT
IDX:SAME
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Sarana Meditama Metropolitan Tbk PT
Note Receivable
Sarana Meditama Metropolitan Tbk PT
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sarana Meditama Metropolitan Tbk PT
IDX:SAME
|
Note Receivable
Rp2.5B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Note Receivable
Rp85.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
10%
|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Note Receivable
Rp54.6B
|
CAGR 3-Years
34%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Note Receivable
Rp6.4B
|
CAGR 3-Years
71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Note Receivable
Rp64.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
Sarana Meditama Metropolitan Tbk PT
Glance View
PT Sarana Meditama Metropolitan Tbk engages in the provision of healthcare services through the Omni Hospital. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 2,581 full-time employees. The company went IPO on 2013-01-11. The firm hospitals are operated under the brand name of EMC Healthcare. The Company’s specialty centers include cardiovascular center, orthopedic center, Kawasaki center, neuroscience center, urology center, oncology surgery center and digestive & bariatric center. The firm operates six hospitals of EMC Hospital Tangerang, EMC Hospital Sentul, EMC Hospital Pulomas, EMC Hospital Alam Sutera, EMC Hospital Cikarang, and EMC Hospital Pekayon. The firm also operates Grha Kedoya Hospital and Grha MM2100 Hospital through subsidiary PT Kedoya Adyaraya Tbk (RSGK). The Company’s subsidiaries include PT Sarana Meditama International, PT Sarana Meditama Anugerah, PT Sarana Meditama Nusantara, PT Kurnia Sejahtera Utama, PT Elang Medika Corpora, PT Sentosa Indah Sejahtera and PT Kedoya Adyaraya Tbk.
See Also
What is Sarana Meditama Metropolitan Tbk PT's Note Receivable?
Note Receivable
2.5B
IDR
Based on the financial report for Sep 30, 2025, Sarana Meditama Metropolitan Tbk PT's Note Receivable amounts to 2.5B IDR.
What is Sarana Meditama Metropolitan Tbk PT's Note Receivable growth rate?
Note Receivable CAGR 10Y
24%
Over the last year, the Note Receivable growth was -53%. The average annual Note Receivable growth rates for Sarana Meditama Metropolitan Tbk PT have been 27% over the past three years , and 24% over the past ten years .
